Third-line docetaxel chemotherapy for recurrent and metastatic gastric cancer

BACKGROUND/AIMS: To determine the efficacy and toxicity of docetaxel as a third-line therapy for patients with relapsed gastric cancer who have undergone modified oxaliplatin-fluorouracil (m-FOLFOX)-4 and modified irinotecan-fluorouracil (m-FOLFIRI) regimens. METHODS: We analyzed 33 patients who had...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ji Hyun, Kim, Sung-Hyun, Oh, Sung Yong, Lee, Suee, Lee, Hojin, Lee, Hye Jung, Kim, Hyo-Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654129/
https://www.ncbi.nlm.nih.gov/pubmed/23682225
http://dx.doi.org/10.3904/kjim.2013.28.3.314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654129/
https://www.ncbi.nlm.nih.gov/pubmed/23682225
http://dx.doi.org/10.3904/kjim.2013.28.3.314

Ejemplares similares